TRPV1 and neoplasm: Administration of capsazepine, an antagonist for TRPV1, has been found to prevent cutaneous vasodilation [55], suggesting that capsazepine may be a promising candidate for prevention of tumor growth, although its ability to prevent metastasis remains unclear.